Open original FDA record ↗Recall record
- FDA identifier
- Z-0914-05
- Company in FDA record
- Esa Biosciences, Inc.
- FDA classification date
- Jun 21, 2005
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Lead test results may be reported lower than the actual value
Source facts
- Action
- ESA is notifying beginning 5/19/05 to Distributors and End Users by letter sent First Class Mail. Additionally Distributors may be notified by phone to ensure receipt of letter. Customers will be asked to return product to ESA for destruction. A fax back form is included with the notification letter. Customers will fax back the number of Test Kits that they require replacement for. ESA will ship replacement kits and include a prepaid return shipping label for the customer to return defective kits to ESA.
- Initiated
- 2005-05-19
- Root cause
- Other
- Terminated
- 2005-11-21
- Distribution
- United States Foreign: Mexico, Canada, Indonesia, Palestine, Kingdom of Saudi Arabia, Columbia, Switzerland, Romania, West Indies, Italy, Japan, Turkey, United Kingdom, Phillipines, Singapore, Jamaica, Uraguay, South Korea, Peru, Tanzia, South Africa, Quatar, Croatia, Zambia, China, Germany
- Recall number
- Z-0914-05
- Recall status
- Terminated
- CDRH record ID
- 39067
- FDA classified
- 2005-06-21
- Recall event number
- 32066